Drugs / PRP
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT07335367 Background | Jan → Aug 2026 | androgenetic alopecia | Nanfang Hospital, Southern Medical University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07335367 ↗ |
| Route | Other | “The PRP will be administered intradermally” NCT07335367 ↗ |